Perdagangan LifeStance Health Group - LFST CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.09 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.030779% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.013666% | ||||||||
Waktu biaya inap | 22:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 5.39 |
Open* | 5.33 |
1-Year Change* | -26.79% |
Day's Range* | 5.33 - 5.63 |
52 wk Range | 4.22-11.25 |
Average Volume (10 days) | 426.81K |
Average Volume (3 months) | 10.43M |
Market Cap | 2.08B |
P/E Ratio | -100.00K |
Shares Outstanding | 375.99M |
Revenue | 820.18M |
EPS | -0.79 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 5.51 | 0.33 | 6.37% | 5.18 | 5.65 | 5.16 |
Feb 2, 2023 | 5.39 | 0.02 | 0.37% | 5.37 | 5.53 | 5.22 |
Feb 1, 2023 | 5.34 | 0.16 | 3.09% | 5.18 | 5.41 | 5.14 |
Jan 31, 2023 | 5.25 | 0.08 | 1.55% | 5.17 | 5.34 | 5.10 |
Jan 30, 2023 | 5.24 | -0.03 | -0.57% | 5.27 | 5.52 | 5.18 |
Jan 27, 2023 | 5.49 | 0.41 | 8.07% | 5.08 | 5.62 | 5.08 |
Jan 26, 2023 | 5.21 | -0.10 | -1.88% | 5.31 | 5.31 | 5.05 |
Jan 25, 2023 | 5.22 | 0.18 | 3.57% | 5.04 | 5.26 | 4.96 |
Jan 24, 2023 | 5.17 | 0.19 | 3.82% | 4.98 | 5.40 | 4.98 |
Jan 23, 2023 | 5.14 | -0.01 | -0.19% | 5.15 | 5.31 | 4.98 |
Jan 20, 2023 | 5.18 | 0.19 | 3.81% | 4.99 | 5.33 | 4.86 |
Jan 19, 2023 | 5.02 | -0.11 | -2.14% | 5.13 | 5.21 | 4.92 |
Jan 18, 2023 | 5.29 | -0.02 | -0.38% | 5.31 | 5.49 | 5.11 |
Jan 17, 2023 | 5.39 | 0.26 | 5.07% | 5.13 | 5.50 | 5.02 |
Jan 13, 2023 | 5.29 | 0.23 | 4.55% | 5.06 | 5.40 | 5.02 |
Jan 12, 2023 | 5.17 | 0.09 | 1.77% | 5.08 | 5.19 | 4.86 |
Jan 11, 2023 | 5.06 | 0.13 | 2.64% | 4.93 | 5.16 | 4.76 |
Jan 10, 2023 | 4.94 | 0.17 | 3.56% | 4.77 | 5.05 | 4.56 |
Jan 9, 2023 | 4.93 | 0.30 | 6.48% | 4.63 | 5.01 | 4.59 |
Jan 6, 2023 | 4.68 | 0.14 | 3.08% | 4.54 | 4.73 | 4.37 |
LifeStance Health Group Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2019 | 2020 | 2021 | |
---|---|---|---|
Total revenue | 212.518 | 377.217 | 667.511 |
Revenue | 212.518 | 377.217 | 667.511 |
Total Operating Expense | 199.463 | 398.965 | 972.026 |
Selling/General/Admin. Expenses, Total | 179.633 | 311.303 | 430.54 |
Depreciation / Amortization | 6.095 | 31.045 | 54.136 |
Unusual Expense (Income) | 2.186 | 37.184 | 21.347 |
Other Operating Expenses, Total | 11.549 | 19.433 | 466.003 |
Operating Income | 13.055 | -21.748 | -304.515 |
Interest Income (Expense), Net Non-Operating | -5.409 | -22.132 | -24.511 |
Other, Net | 0.229 | -0.531 | -4.079 |
Net Income Before Taxes | 7.875 | -44.411 | -333.105 |
Net Income After Taxes | 5.669 | -38.07 | -307.197 |
Net Income Before Extra. Items | 5.669 | -38.07 | -307.197 |
Net Income | 5.669 | -38.07 | -307.197 |
Total Adjustments to Net Income | -64.573 | -273.244 | -36.75 |
Income Available to Common Excl. Extra. Items | -58.904 | -311.314 | -343.947 |
Income Available to Common Incl. Extra. Items | -58.904 | -311.314 | -343.947 |
Diluted Net Income | -58.904 | -311.314 | -343.947 |
Diluted Weighted Average Shares | 373.649 | 373.649 | 327.523 |
Diluted EPS Excluding Extraordinary Items | -0.15765 | -0.83317 | -1.05015 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |
Diluted Normalized EPS | -0.15343 | -0.7687 | -0.97291 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
Revenue | 143.132 | 160.549 | 173.835 | 189.995 | 203.095 |
Total Operating Expense | 145.547 | 223.99 | 298.629 | 303.86 | 268.224 |
Selling/General/Admin. Expenses, Total | 32.019 | 84.935 | 162.047 | 151.539 | 101.575 |
Depreciation / Amortization | 12.228 | 12.774 | 13.777 | 15.357 | 15.684 |
Unusual Expense (Income) | 2.166 | 16.94 | 1.022 | 1.219 | 2.072 |
Other Operating Expenses, Total | 99.134 | 109.341 | 121.783 | 135.745 | 148.893 |
Operating Income | -2.415 | -63.441 | -124.794 | -113.865 | -65.129 |
Interest Income (Expense), Net Non-Operating | -8.632 | -8.774 | -3.503 | -3.602 | -3.441 |
Other, Net | -0.396 | -1.606 | -0.906 | -1.171 | -0.434 |
Net Income Before Taxes | -11.443 | -73.821 | -129.203 | -118.638 | -69.004 |
Net Income After Taxes | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
Net Income Before Extra. Items | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
Net Income | -8.682 | -70.033 | -120.452 | -108.03 | -62.328 |
Total Adjustments to Net Income | -36.75 | 0 | 0 | 0 | 0 |
Income Available to Common Excl. Extra. Items | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
Income Available to Common Incl. Extra. Items | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
Diluted Net Income | -45.432 | -70.033 | -120.452 | -108.03 | -62.328 |
Diluted Weighted Average Shares | 373.649 | 313.536 | 343.394 | 346.243 | 350.849 |
Diluted EPS Excluding Extraordinary Items | -0.12159 | -0.22337 | -0.35077 | -0.31201 | -0.17765 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.11782 | -0.14689 | -0.34883 | -0.31418 | -0.17381 |
- Annual
- Quarterly
2019 | 2020 | 2021 | |
---|---|---|---|
Total Current Assets | 27.425 | 76.28 | 266.52 |
Cash and Short Term Investments | 3.481 | 18.829 | 148.029 |
Cash & Equivalents | 3.481 | 18.829 | 148.029 |
Total Receivables, Net | 19.13 | 46.934 | 94.695 |
Accounts Receivable - Trade, Net | 18.633 | 43.706 | 76.078 |
Prepaid Expenses | 4.814 | 10.517 | 19.454 |
Total Assets | 280.779 | 1569.73 | 1927.11 |
Property/Plant/Equipment, Total - Net | 22.426 | 59.349 | 152.242 |
Property/Plant/Equipment, Total - Gross | 26.717 | 63.781 | 171.768 |
Accumulated Depreciation, Total | -4.291 | -4.432 | -19.526 |
Goodwill, Net | 214.614 | 1098.66 | 1204.54 |
Intangibles, Net | 14.951 | 332.796 | 300.355 |
Other Long Term Assets, Total | 1.363 | 2.647 | 3.448 |
Total Current Liabilities | 55.007 | 75.921 | 116.752 |
Accounts Payable | 3.642 | 7.688 | 14.152 |
Accrued Expenses | 23.545 | 46.98 | 76.055 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Other Current Liabilities, Total | 27.82 | 17.515 | 25.222 |
Total Liabilities | 144.221 | 536.895 | 382.081 |
Total Long Term Debt | 79.314 | 362.534 | 157.416 |
Long Term Debt | 79.314 | 362.534 | 157.416 |
Deferred Income Tax | 0.863 | 81.226 | 54.281 |
Other Liabilities, Total | 9.037 | 17.214 | 53.632 |
Total Equity | 136.558 | 1032.84 | 1545.03 |
Preferred Stock - Non Redeemable, Net | 302.913 | 0 | 0 |
Common Stock | 0.003 | 1044.51 | 3.743 |
Additional Paid-In Capital | 0 | 1.452 | 1898.36 |
Retained Earnings (Accumulated Deficit) | -166.358 | -13.125 | -357.072 |
Total Liabilities & Shareholders’ Equity | 280.779 | 1569.73 | 1927.11 |
Total Common Shares Outstanding | 373.649 | 373.649 | 374.255 |
Current Port. of LT Debt/Capital Leases | 3.738 | 1.323 | |
Other Current Assets, Total | 4.342 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 109.578 | 364.06 | 328.326 | 266.52 | 263.297 |
Cash and Short Term Investments | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
Cash & Equivalents | 39.494 | 276.187 | 212.123 | 148.029 | 113.99 |
Total Receivables, Net | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
Accounts Receivable - Trade, Net | 47.768 | 60.069 | 70.059 | 76.078 | 94.991 |
Prepaid Expenses | 22.316 | 27.804 | 46.144 | 42.413 | 54.316 |
Total Assets | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
Property/Plant/Equipment, Total - Net | 70.802 | 91.799 | 115.049 | 152.242 | 170.927 |
Property/Plant/Equipment, Total - Gross | 77.843 | 101.91 | 129.125 | 171.768 | 196.18 |
Accumulated Depreciation, Total | -7.041 | -10.111 | -14.076 | -19.526 | -25.253 |
Goodwill, Net | 1099.68 | 1138.73 | 1160.01 | 1204.54 | 1229.3 |
Intangibles, Net | 323.302 | 316.534 | 307.982 | 300.355 | 291.18 |
Other Long Term Assets, Total | 2.926 | 3.3 | 3.388 | 3.448 | 3.679 |
Total Current Liabilities | 96.757 | 112.558 | 105.205 | 116.752 | 125.597 |
Accounts Payable | 5.913 | 9.958 | 3.074 | 14.152 | 15.136 |
Accrued Expenses | 71.024 | 89.163 | 85.934 | 86.512 | 95.014 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 19.82 | 11.818 | 14.874 | 14.765 | 14.124 |
Total Liabilities | 580.524 | 369.795 | 369.887 | 382.081 | 415.868 |
Total Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
Long Term Debt | 387.298 | 157.067 | 157.447 | 157.416 | 177.38 |
Deferred Income Tax | 81.226 | 81.219 | 81.226 | 54.281 | 54.281 |
Other Liabilities, Total | 15.243 | 18.951 | 26.009 | 53.632 | 58.61 |
Total Equity | 1025.76 | 1544.63 | 1544.87 | 1545.03 | 1542.52 |
Common Stock | 1082.26 | 3.742 | 3.742 | 3.743 | 3.744 |
Additional Paid-In Capital | 2.057 | 1669.48 | 1790.17 | 1898.36 | 1958.17 |
Retained Earnings (Accumulated Deficit) | -58.557 | -128.59 | -249.042 | -357.072 | -419.4 |
Total Liabilities & Shareholders’ Equity | 1606.28 | 1914.43 | 1914.76 | 1927.11 | 1958.39 |
Total Common Shares Outstanding | 373.649 | 373.649 | 374.149 | 374.255 | 374.323 |
Current Port. of LT Debt/Capital Leases | 1.619 | 1.323 | 1.323 | 1.323 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 |
- Annual
- Quarterly
2019 | 2020 | 2021 | |
---|---|---|---|
Net income/Starting Line | 5.669 | -38.07 | -307.197 |
Cash From Operating Activities | 17.048 | -8.533 | 9.42 |
Cash From Operating Activities | 6.095 | 31.045 | 54.136 |
Deferred Taxes | 1.76 | -6.501 | -26.945 |
Non-Cash Items | 0.532 | 5.746 | 287.286 |
Cash Taxes Paid | 0.254 | 0.246 | 1.093 |
Cash Interest Paid | 4.582 | 17.149 | 22.415 |
Changes in Working Capital | 2.992 | -0.753 | 2.14 |
Cash From Investing Activities | -73.375 | -861.169 | -194.076 |
Capital Expenditures | -14.314 | -38.066 | -94.492 |
Other Investing Cash Flow Items, Total | -59.061 | -823.103 | -99.584 |
Cash From Financing Activities | 48.463 | 912.274 | 313.856 |
Financing Cash Flow Items | -6.987 | 600.867 | -11.18 |
Issuance (Retirement) of Stock, Net | 0 | 20 | 549.905 |
Issuance (Retirement) of Debt, Net | 55.45 | 291.407 | -224.869 |
Net Change in Cash | -7.864 | 42.572 | 129.2 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -8.682 | -78.715 | -199.167 | -307.197 | -62.328 |
Cash From Operating Activities | 9.909 | -7.006 | -21.215 | 9.42 | 3.308 |
Cash From Operating Activities | 12.228 | 25.002 | 38.779 | 54.136 | 15.684 |
Deferred Taxes | 0 | 0 | 0 | -26.945 | |
Non-Cash Items | 1.315 | 46.378 | 168.39 | 287.286 | 60.584 |
Cash Interest Paid | 6.806 | 24.889 | 28.217 | 22.415 | 3.091 |
Changes in Working Capital | 5.048 | 0.329 | -29.217 | 2.14 | -10.632 |
Cash From Investing Activities | -11.835 | -70.929 | -114.514 | -194.076 | -50.855 |
Capital Expenditures | -11.081 | -31.803 | -55.815 | -94.492 | -27.91 |
Other Investing Cash Flow Items, Total | -0.754 | -39.126 | -58.699 | -99.584 | -22.945 |
Cash From Financing Activities | 22.591 | 335.293 | 329.023 | 313.856 | 13.508 |
Financing Cash Flow Items | -2.824 | -7.947 | -8.622 | -11.18 | -6.161 |
Issuance (Retirement) of Stock, Net | 0 | 555.169 | 549.905 | 549.905 | |
Issuance (Retirement) of Debt, Net | 25.415 | -211.929 | -212.26 | -224.869 | 19.669 |
Net Change in Cash | 20.665 | 257.358 | 193.294 | 129.2 | -34.039 |
Cash Taxes Paid | 0.9 | 0.908 | 1.093 | -0.06 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
TPG Capital, L.P. | Private Equity | 46.6199 | 175284635 | 0 | 2022-09-30 | LOW |
Summit Partners, L.P. | Private Equity | 12.1639 | 45734703 | 0 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 7.5946 | 28554650 | -2973463 | 2022-09-30 | LOW |
Lester (Michael K.) | Individual Investor | 5.7172 | 21495968 | -328615 | 2022-06-13 | LOW |
Silversmith Capital Partners | Private Equity | 5.1973 | 19541192 | 0 | 2021-12-31 | |
Qureshi (Danish J.) | Individual Investor | 2.5754 | 9683096 | -85879 | 2022-06-13 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.8602 | 6994133 | 832246 | 2022-09-30 | LOW |
Stockbridge Partners LLC | Investment Advisor/Hedge Fund | 1.8169 | 6831137 | 15000 | 2022-09-30 | LOW |
Booth (Gwendolyn H.) | Individual Investor | 1.7375 | 6532649 | -88798 | 2022-06-13 | LOW |
Gouk (Warren) | Individual Investor | 1.586 | 5962991 | -15106 | 2022-11-07 | LOW |
Mullins (Kevin Michael) | Individual Investor | 1.4853 | 5584540 | -82520 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2332 | 4636558 | 937454 | 2022-09-30 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 1.0256 | 3856290 | 488665 | 2022-09-30 | LOW |
Bessler (Robert) | Individual Investor | 0.8087 | 3040694 | 0 | 2022-04-06 | LOW |
Fidelity Institutional Asset Management | Investment Advisor | 0.6928 | 2604875 | 1070087 | 2022-09-30 | LOW |
Rock Springs Capital Management LP | Hedge Fund | 0.5319 | 2000000 | 0 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4645 | 1746348 | 502175 | 2022-09-30 | LOW |
Bruff (Jesse Michael) | Individual Investor | 0.4239 | 1586606 | -230098 | 2022-04-25 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3729 | 1402221 | 256009 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.3515 | 1321716 | -149365 | 2021-12-31 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group +485000+
Trader
65000+
Klien aktif per bulan
$48000000+
Volume investasi per bulan
$28000000+
Coba sekarang Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Healthcare Facilities & Services (NEC) |
4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com